Laura Chu

Laura Chu is an experienced professional in the pharmaceutical industry, currently serving as an Associate Director and Key Account Manager at Alnylam Pharmaceuticals since January 2024. Prior to this role, Laura held positions at Sandoz as Regional Access Manager and Key Account Manager, specializing in Multiple Sclerosis, from April 2022 to January 2024. Previous experience includes Senior Key Account Manager at GW Pharmaceuticals plc, focusing on Multiple Sclerosis, and Senior Area Business Manager at Biogen, with an emphasis on Neurology. Laura started the career as a Senior Hospital Specialist at UCB, working with Parkinson’s disease and Epilepsy. Laura holds a BSc in Biotechnology with Management (Hons) from London South Bank University, completed from 1991 to 1995.